We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
2076
DELISTED
Cardiovascular Systems, Inc.
CSII
| $749K | ﹤0.01% |
31,626
-6,442
| -17% | -$162K |
|
|
OSG
2077
Octave Specialty Group
OSG
$243M
| $743K | ﹤0.01% |
46,497
-7,620
| -14% | -$117K |
|
2078
Barnes & Noble Education
BNED
$431M
| $740K | ﹤0.01% |
899
+106
| +13% | +$70.1K |
|
|
UCTT
2079
Ultra Clean Holdings
UCTT
$3.73B
| $740K | ﹤0.01% |
32,028
-5,916
| -16% | -$152K |
|
|
CONN
2080
DELISTED
Conn's Inc.
CONN
| $740K | ﹤0.01% |
20,825
-3,456
| -14% | -$106K |
|
2081
Beazer Homes USA
BZH
$877M
| $739K | ﹤0.01% |
38,450
-5,928
| -13% | -$119K |
|
2082
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $738K | ﹤0.01% |
33,215
-6,863
| -17% | -$161K |
|
2083
Preferred Bank
PFBC
$1.24B
| $738K | ﹤0.01% |
12,561
-2,254
| -15% | -$137K |
|
|
REN
2084
DELISTED
Resolute Energy Corporaton
REN
| $737K | ﹤0.01% |
23,425
-4,029
| -15% | -$117K |
|
|
KMG
2085
DELISTED
KMG Chemicals Inc
KMG
| $732K | ﹤0.01% |
11,070
+438
| +4% | +$24.8K |
|
2086
TFS Financial
TFSL
$5.16B
| $731K | ﹤0.01% |
48,938
-445
| -0.9% | -$6.85K |
|
|
ACET
2087
DELISTED
Aceto Corp
ACET
| $730K | ﹤0.01% |
70,645
+10,638
| +18% | +$112K |
|
|
SP
2088
DELISTED
SP Plus Corporation
SP
| $729K | ﹤0.01% |
19,639
-3,198
| -14% | -$124K |
|
2089
Quad
QUAD
$536M
| $728K | ﹤0.01% |
32,216
-5,310
| -14% | -$120K |
|
2090
Laureate Education
LAUR
$5.28B
| $725K | ﹤0.01% |
53,458
+7,502
| +16% | +$98.3K |
|
|
GPMT
2091
Granite Point Mortgage Trust
GPMT
$69M
| $722K | ﹤0.01% |
+40,690
| New | +$740K |
|
|
GHDX
2092
DELISTED
Genomic Health, Inc.
GHDX
| $719K | ﹤0.01% |
21,023
-3,911
| -16% | -$125K |
|
|
RESI
2093
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $716K | ﹤0.01% |
60,400
-9,153
| -13% | -$101K |
|
|
CNR
2094
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $713K | ﹤0.01% |
36,952
-7,145
| -16% | -$120K |
|
|
TRUE
2095
DELISTED
TrueCar
TRUE
| $712K | ﹤0.01% |
63,605
-7,560
| -11% | -$99.5K |
|
2096
Glaukos
GKOS
$9.83B
| $710K | ﹤0.01% |
27,697
-5,117
| -16% | -$152K |
|
2097
Lattice Semiconductor
LSCC
$17.6B
| $705K | ﹤0.01% |
121,934
-21,940
| -15% | -$129K |
|
|
ALDR
2098
DELISTED
Alder Biopharmaceuticals
ALDR
| $704K | ﹤0.01% |
61,446
-9,888
| -14% | -$110K |
|
2099
QuinStreet
QNST
$890M
| $700K | ﹤0.01% |
83,538
+10,226
| +14% | +$86.8K |
|
2100
NN Inc
NNBR
$255M
| $699K | ﹤0.01% |
25,335
-4,768
| -16% | -$135K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.